Alaunos Therapeutics, Inc. · NASDAQ:TCRT

Weis Holger received 7,761 Alaunos Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 12, 2026 · Filed Jun 17, 2026

On Jun 12, 2026, Weis Holger (Chief Executive Officer) received 7,761 Alaunos Therapeutics, Inc. shares as an award at US$2.26 for US$17,540, leaving 12,672 shares. Filed Jun 17, 2026 (Form 4).

Awarded
7,761 shares
Price
US$2.26
Value
US$17,540
Holding after
12,672 shares
Trading plan
No
Role
Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 12, 2026Common StockAward7,761US$2.2612,672Direct

Source

View original at SEC

Related